Skip to main content

The PERSEVERE Study

Recruiting · Not applicable · NCT06588634

Conditions: Pulmonary Embolism, Pulmonary Thromboembolism

At a glance

Research payments reported, 2025
$213,070
U.S. investigators named
11
Sites paid
11
Planned or actual enrollment
200

About the trial

Sponsor
Inari Medical
Tested
FlowTriever System (device), Standard of Care (procedure)
Dates
Started 2024-12-16; completion 2028-02
Results posted
Not yet

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care

From ClinicalTrials.gov, last updated 2026-10-08. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Stryker Corporation reported $213,070 in research payments for this study in 2025 (74 payments).

Products named: Flowtriever Catheter, S

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.